Download 348-3600-1-SP - Journal of the ASEAN Federation of

References
1. Curado MP, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents,
vol. IX. Lyon: International Agency for Research on Cancer, 2007.
2. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review,
1975-2012,
National
Cancer
Institute,
Bethesda,
MD.
http://seer.cancer.gov/csr/1975_2012/, accessed April 2015.
3. Ferlay J1, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality
worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J
Cancer. 2015;136(5):E359-86.
4. Redaniel MTM, Laudico AV, Lumague MRM, Mapua CA, Patama T, Pukkala
E. Cancer in the Philippines, Vol IV Part 1 Cancer Incidence 1998-2002.
Manila: Philippine Cancer Society, 2008.
5. Grodski S, Brown T, Sidhu S, et al. Increasing incidence of thyroid cancer is
due to increased pathologic detection. Surgery. 2008;144(6):1038-43.
6. Mendoza A, Shaffer B, Karakla D, Mason ME, Elkins D, Goffman TE. Quality
of life with well-differentiated thyroid cancer: treatment toxicities and their
reduction. Thyroid. 2004;14(2):133-40.
7. Biondi B, Fazio S, Carella C, et al. Control of adrenergic overactivity by betablockade improves the quality of life in patients receiving long term suppressive
therapy with levothyroxine. J Clin Endocrinol Metab. 1994;78(5):1028-33.
8. Almeida, JP, Vartanian, JG, Kowalski, LP. Clinical predictors of quality of life
in patients with initial differentiated thyroid cancers. Arch Otolaryngol Head
Neck Surg. 2009;135(4):342-6.
9. Rubic M, Kuna SK, Tesic V, Samardzic T, Despot M, Huic D. The most
common factors influencing on quality of life of thyroid cancer patients after
thyroid hormone withdrawal. Psychiatr Danub. 2014;26 Suppl 3:520-7.
10. Gómez M, Gutiérrez R, Castellanos S, Vergara M, Pradilla Y. Psychological
well-being and quality of life in patients treated for thyroid cancer after surgery.
Terapia Psicologica. 2010:28(1):69-84.
11. Centers for Disease Control and Prevention. Measuring healthy days:
Population assessment of health-related quality of life. Atlanta, Georgia:
Centers for Disease Control and Prevention, 2000.
12. Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV.
Health-related quality of life among thyroid cancer survivors: A systematic
review. Clin Endocrinol (Oxf). 2011;75:544–54.
13. Tan LG, Nan L, Thumboo J, Sundram F, Tan L. Health-related quality of life in
thyroid cancer survivors. Laryngoscope. 2007;117(3):507-10.
14. Lee JI, Kim SH, Tan AH, et al. Decreased health-related quality of life in
disease-free survivors of differentiated thyroid cancer in Korea. Health Qual
Life Outcomes. 2010;15;8:101.
15. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for
Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for
use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–
76.
16. Husson O, Haak HR, Mols F, et al. Development of a disease-specific healthrelated quality of life questionnaire (THYCA-QoL) for thyroid cancer
survivors. Acta Oncol. 2013;52(2):447-54
17. Johnson, C, Aaronson N, Blazeby JM, et al. EORTC Quality of Life Group
Guidelines for Developing Questionnaire Modules, 4th Edition. April 2011.
18. Nunnally JC, Bernstein IH. Psychometric theory. New York: McGraw-Hill,
1994.
19. Jeong Y, Choi J, Ahn A, et al. Validation of the Korean version of the thyroid
cancer-specific quality of life questionnaire. Ann Surg Treat Res. 2015;89(6):
287–294.
20. Dow KH, Ferrell BR, Anello C. Quality-of-life changes in patients with thyroid
cancer after withdrawal of thyroid hormone therapy. Thyroid. 1997;7:613–9.
21. EORTC
QOL
Module
for
Thyroid
Cancer
(QLQ-THY).
http://groups.eortc.be/qol/eortc-qol-module-thyroid-cancer-qlq-thy.